Healthcare Industry News: American Medical Systems
News Release - June 30, 2010
AMS Receives 510(k) Clearance of Its Revolutionary MoXy(TM) Liquid Cooled Fiber for Fast, Safe Treatment of Enlarged ProstateMINNETONKA, Minn., June 30 (Healthcare Sales & Marketing Network) -- American Medical Systems® (AMS) (Nasdaq:AMMD ), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the 510(k) clearance of its revolutionary MoXy™ Liquid Cooled Fiber.
"The MoXy fiber gives physicians the ability to utilize the GreenLight XPS system to its full potential for the treatment of enlarged prostate," said Joe Martin, senior vice president and general manager of BPH Therapies at AMS. "Vaporization efficiency is significantly improved to enable the removal of twice the tissue—as compared to our GreenLight HPS system— to effectively cut treatment time in half."
"GreenLight™ laser technology has significantly improved since the global introduction of the original 80-watt PV system in 2002," stated Dr. Reza Malek, who invented the procedure commonly known as Photoselective Vaporization of the Prostate (PVP) utilizing a prototype 60-watt system at the Mayo Clinic in 1997. "The 180-watt XPS system with the revolutionary MoXy fiber allows us to treat BPH faster and more safely than ever before, which is very exciting not only for us as clinicians, but also for our patients."
GreenLight XPS with the MoXy fiber is the latest in AMS' world-class portfolio of innovative, technologically advanced solutions to treat a variety of pelvic health conditions. Through its commitment to innovation and continuous improvement, AMS has become the recognized technology leader in both the men's and women's pelvic health markets. For more information about GreenLight XPS and MoXy, visit www.AMSGreenLight.com.
About American Medical Systems:
American Medical Systems, headquartered in Minnetonka, Minnesota, is a diversified supplier of medical devices and procedures to cure incontinence, erectile dysfunction, benign prostate hyperplasia (BPH), pelvic floor repair and other pelvic disorders in men and women. These disorders can significantly diminish one's quality of life and profoundly affect social relationships. In recent years, the number of people seeking treatment has increased markedly as a result of longer lives, higher quality-of-life expectations and greater awareness of new treatment alternatives. American Medical Systems' products reduce or eliminate the incapacitating effects of these diseases, often through minimally invasive therapies. The company's products were used to treat more than 335,000 patients in 2009.
More information about the company and its products can be found at www.AmericanMedicalSystems.com and in the Company's Annual Report on Form 10-K for 2009 and its other SEC filings.
Source: American Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.